Archive for the 'Lung Cancer' Category


Lung Cancer - NICE Recommends Oral Tarceva(R) (erlotinib) As An Alternative To Intravenous Chemotherapy, UK

Today the National Institute for Health and Clinical Excellence (NICE) recommends Tarceva (erlotinib) as a clinically and cost-effective alternative to IV chemotherapy (i.e. docetaxel) for the 2nd line treatment of non-small cell lung cancer.2 This is the first new drug recommended in non-small cell lung cancer for seven years and will give patients access to an oral treatment for this devastating disease without many of the side effects associated with IV chemotherapy.
(more...)


11/26/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

European Cancer Specialists Mandate For Change - Better Emotional Support And Resouces For Lung Cancer Patients

A coalition of European cancer specialists today called for major changes in the provision of emotional support for lung cancer patients. In conjunction with the International Psycho-Oncology Society, they issued a Mandate for Change, highlighting basic rights for patients in terms of their emotional wellbeing and quality of life. Lung cancer is Europe's most common cancer killer, claiming almost 1,000 lives every day.
(more...)


11/25/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

Lung Cancer Needs Awareness Too

Lung cancer kills more than four times as many Americans as breast cancer. But while pink ribbons trumpet Breast Cancer Awareness Month throughout October, little attention is paid to lung cancer in November, which is that disease's awareness month. "My wish is the world would stand up and say we've done so well with breast cancer, let's now do the same for lung cancer," says Douglas Arenberg, M.D.
(more...)


11/24/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

Mesothelioma Victims Center Offers The Best Free Help & Advice Service For A Victim Of Mesothelioma

The Mesothelioma Victims Center is a world class free service designed to assist all victims of Mesothelioma, or to assist the families of victims, who have this disease. The group has just expanded its service to assist Mesothelioma victims or their families to find the right law firm to help them. According to Americas Watchdog, "we want the victims of this horrible disease get the absolute best legal advice; not a law firm that will simply refer the case onto someone else.
(more...)


11/24/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

Oral Gefitinib As Effective As Injected Docetaxel For Survival Of Patients With Non-Small-Cell Lung Cancer (Interest Study)

Gefitnib is as effective a second-line treatment as docetaxel for patients with non-small cell* lung cancer. The INTEREST study, published in an Article in this week's edition of The Lancet, thus establishes gefitinib as a valid treatment option for people with this condition. The study was written by Dr Edward Kim, M. D. Anderson Cancer Center, Houston, Texas, USA and colleagues.
(more...)


11/21/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

Extending Chemotherapy Improves Control Of Lung Cancer

A new Australian study has found that extending the use of chemotherapy in patients with advanced non-small cell lung cancer better controls the disease, as well as providing a modest improvement in survival. The study will be reported today (18/11) to the Clinical Oncolgoical Society of Australia Annual Scientific Meeting in Sydney.
(more...)


11/18/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

First Pivotal Trials Begin For Boehringer Ingelheim’s Novel Triple Angiokinase Inhibitor Vargatef™ (BIBF 1120)

Boehringer Ingelheim has marked a new milestone within its rapidly expanding oncology portfolio with the announcement today that the company has progressed another of its oncology compounds into pivotal phase III clinical development.
(more...)


11/17/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

Phase 2 Study Of IMC-1121B In First-Line Treatment Of Advanced Non-Small Cell Lung Cancer Starts Patient Enrollment

ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed Phase 2 clinical trial of IMC-1121B in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC) has opened for patient enrollment. IMC-1121B is ImClone's proprietary fully human, IgG1 anti-vascular growth factor receptor-2 (VEGFR-2) monoclonal antibody.
(more...)


11/13/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

Lung Cancer Rates Dropping But Hospitalization Rates Remain Constant, USA

Hospital admissions for lung cancer remained relatively stable - at roughly 150,000 a year between 1995 and 2006 - despite a steady decline in the number of Americans diagnosed with the disease, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
(more...)


11/13/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

Survey Shows Lung Cancer Patients Blamed For Their Diagnosis

Survey results released today show that the general population blames lung cancer patients for their diagnosis, confirming the stigma that patients reportedly feel. Findings also demonstrate a lack of public support for patients and a need for greater research for the number one cancer killer.
(more...)


11/13/2008 | Respiratory & Asthma - Lung Cancer | Trackback | Comments Off

« Previous Entries

© 2006 MBGJ.Org Limited Trading as Natural-Remedies-Clinic

All rights reserved - Designated trademarks and brands are the property of their respective owners

Natural Remedies Clinic - Main Site


Page Sponsors

Scar Tissue -Mobility Scooters -Back Surgery

>-- Top of Page --<